Task: Answer the multiple-choice question.
Question: Which drug exhibits a -4.313% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a CCC(=O)N(Cc1cc2cccc(C)c2[nH]c1=O)c1ccccc1OC
b Cc1cccc(C)c1NC(=O)CCCSc1nnc(-c2ccc(Cl)cc2)n1-c1ccccc1
c CC1CCN(C(=O)COc2cccc3c2CCN(Cc2ccccc2)C3=O)CC1
Answer: a. CCC(=O)N(Cc1cc2cccc(C)c2[nH]c1=O)c1ccccc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(=O)N(Cc1cc2cccc(C)c2[nH]c1=O)c1ccccc1OC
CCC(=O)N(Cc1cc2cccc(C)c2[nH]c1=O)c1ccccc1OC
N-(2-methoxyphenyl)-N-[(8-methyl-2-oxo-1H-quinolin-3-yl)methyl]propanamide